XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Public Offering
Common Stock
Common Stock
Public Offering
Additional Paid-in Capital
Additional Paid-in Capital
Public Offering
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at Dec. 31, 2020 $ 306,223   $ 4   $ 372,764   $ (5) $ (66,540)
Balance, Shares at Dec. 31, 2020     37,569          
Issuance of common stock upon exercise of stock options 24       24      
Issuance of common stock upon exercise of stock options, Shares     31          
Vesting of early exercise options 10       10      
Stock-based compensation 3,701       3,701      
Net loss (23,844)             (23,844)
Other comprehensive gain (loss) 2           2  
Balance at Mar. 31, 2021 286,116   $ 4   376,499   (3) (90,384)
Balance, Shares at Mar. 31, 2021     37,600          
Balance at Dec. 31, 2020 306,223   $ 4   372,764   (5) (66,540)
Balance, Shares at Dec. 31, 2020     37,569          
Net loss (50,197)              
Balance at Jun. 30, 2021 264,480   $ 4   381,213     (116,737)
Balance, Shares at Jun. 30, 2021     37,665          
Balance at Mar. 31, 2021 286,116   $ 4   376,499   (3) (90,384)
Balance, Shares at Mar. 31, 2021     37,600          
Issuance of common stock upon exercise of stock options 98       98      
Issuance of common stock upon exercise of stock options, Shares     51          
Issuance of common stock under employee stock purchase plan 318       318      
Issuance of common stock under employee stock purchase plan, Shares     14          
Vesting of early exercise options 9       9      
Stock-based compensation 4,289       4,289      
Net loss (26,353)             (26,353)
Other comprehensive gain (loss) 3           3  
Balance at Jun. 30, 2021 264,480   $ 4   381,213     (116,737)
Balance, Shares at Jun. 30, 2021     37,665          
Balance at Dec. 31, 2021 381,430   $ 5   566,161   (187) (184,549)
Balance, Shares at Dec. 31, 2021     47,754          
Issuance of common stock upon exercise of stock options 10       10      
Issuance of common stock upon exercise of stock options, Shares     7          
Vesting of early exercise options 1       1      
Issuance of common stock in public offerings, net of issuance costs   $ 24,103       $ 24,103    
Issuance of common stock in public offerings, net of issuance costs, Shares       1,520        
Stock-based compensation 6,238       6,238      
Net loss (34,235)             (34,235)
Other comprehensive gain (loss) (1,839)           (1,839)  
Balance at Mar. 31, 2022 375,708   $ 5   596,513   (2,026) (218,784)
Balance, Shares at Mar. 31, 2022     49,281          
Balance at Dec. 31, 2021 $ 381,430   $ 5   566,161   (187) (184,549)
Balance, Shares at Dec. 31, 2021     47,754          
Issuance of common stock upon exercise of stock options, Shares 12              
Net loss $ (79,925)              
Balance at Jun. 30, 2022 374,351   $ 5   641,806   (2,986) (264,474)
Balance, Shares at Jun. 30, 2022     52,081          
Balance at Mar. 31, 2022 375,708   $ 5   596,513   (2,026) (218,784)
Balance, Shares at Mar. 31, 2022     49,281          
Issuance of common stock upon exercise of stock options 4       4      
Issuance of common stock upon exercise of stock options, Shares     5          
Issuance of common stock under employee stock purchase plan 499       499      
Issuance of common stock under employee stock purchase plan, Shares     49          
Vesting of early exercise options 1       1      
Issuance of common stock in public offerings, net of issuance costs   $ 38,281       $ 38,281    
Issuance of common stock in public offerings, net of issuance costs, Shares       2,746        
Stock-based compensation 6,508       6,508      
Net loss (45,690)             (45,690)
Other comprehensive gain (loss) (960)           (960)  
Balance at Jun. 30, 2022 $ 374,351   $ 5   $ 641,806   $ (2,986) $ (264,474)
Balance, Shares at Jun. 30, 2022     52,081